Nightingale Informatix Corporation unveils its next generation cloud-based Electronic Health Record Platform NightingaleEHR (Nexia)
Nightingale launches NightingaleEHR, Nexia Release 6
MARKHAM, ON, July 17, 2014 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a cloud-based provider of electronic health record (EHR) software and related services, today unveils NightingaleEHR (Nexia), its next generation cloud-based Electronic Health Record Platform.
"NightingaleEHR is another substantial milestone," said Sam Chebib, President & CEO of Nightingale. "Our next generation product combines the robust functionality Nightingale has delivered over the past 12 years with a state of the art technology platform designed around five key principles: device and platform agnostic; predictive workflow with zero-based training needs; role based and workflow driven; highly interoperable; and multi-lingual support which delivers a new level of value to healthcare providers."
This product will be available to Nightingale's prospects in the Ontario and US markets in August and later in the year for other Canadian provinces. It will address the traditional Enterprise market that Nightingale has historically led and will be made available to smaller clinics through the Company's new self-service model.
NightingaleEHR is currently being used by several hundred users across pilot and earlier adopter sites, and additionally, several hundred more clients that have either committed to buying the product or are awaiting the general availability.
"We believe that the North American EMR market is crowded with legacy products and that NightingaleEHR will be a game-changer" added Chebib. "Over the past 30 months we have invested over $12 million designing and building NightingaleEHR and the feedback from both current and prospective users has been extremely positive and very encouraging. It validates our vision & strategy of simplifying healthcare management through the use best of breed technology."
The Company is planning to migrate all 20,000 users and 17 million patient records on its current platform to Nexia starting early next year.
About Nightingale
For more than a decade, Nightingale (TSX-V: NGH) has been delivering innovative cloud-based Electronic Health Record (EHR) and Practice Management solutions to healthcare organizations across the United States and Canada. Our goal is to uncomplicate the day-to-day challenges of healthcare providers. We achieve this by creating software that is truly intuitive—minimizing training and maximizing adoption. We believe so strongly in building easy-to-use software that we structured our entire product team around user-centric design. Our clients are benefiting from this focus through a well-supported and robust solution that presents a holistic view of a person's well-being in a simple, clean interface, so that the best health decisions can be made. Nightingale - One Patient. One Record. www.nightingalemd.com
Forward Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.
Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Nightingale Informatix Corporation
Media Inquiries
Brittany Quemby, Marketing Manager
Nightingale Informatix Corporation
Tel: 905-307-6867
[email protected]
Investor Inquiries
Marc Lakmaaker, Senior Account Executive
TMX Equicom
Tel: 416-815-0700 ext. 248
[email protected]
Share this article